MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,193,069 | +395.4% | 32,089 | +503.7% | 0.05% | +257.1% |
| Q4 2022 | $240,823 | -72.1% | 5,315 | -57.0% | 0.01% | -74.1% |
| Q3 2022 | $864,000 | -59.3% | 12,367 | -52.1% | 0.05% | -34.9% |
| Q1 2022 | $2,123,000 | +188.5% | 25,822 | +414.8% | 0.08% | +151.5% |
| Q4 2021 | $736,000 | +35.3% | 5,016 | +63.0% | 0.03% | +6.5% |
| Q3 2021 | $544,000 | -82.0% | 3,077 | -83.5% | 0.03% | -84.0% |
| Q2 2021 | $3,015,000 | +302.0% | 18,665 | +326.0% | 0.19% | +424.3% |
| Q1 2021 | $750,000 | -67.4% | 4,381 | -58.1% | 0.04% | -63.0% |
| Q4 2020 | $2,299,000 | – | 10,466 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |